The tender offer is being made in connection with the Agreement and Plan of Merger, dated as of 2 May, by and among DSM, Biomedical Acquisition Corporation and Kensey Nash, which DSM and Kensey Nash announced on 3 May.
The Kensey Nash board of directors has unanimously determined that, among other things, the offer is fair to and in the best interests of Kensey Nash’s stockholders and unanimously recommends that Kensey Nash’s stockholders accept the offer and tender their shares.
Source: DSM
© FoodBev Media Ltd 2024